title: Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy.
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Hinds
authors.forename: Marilyn
authors.initials: M
authors.lastname: Hockenberry
authors.forename: James
authors.initials: J
authors.lastname: Feusner
authors.forename: Jeffrey D
authors.initials: JD
authors.lastname: Hord
authors.forename: Wayne
authors.initials: W
authors.lastname: Rackoff
authors.forename: Bassem I
authors.initials: BI
authors.lastname: Rozzouk
mesh_terms: D000293:Adolescent; D000740:Anemia / Q000097:blood* / Q000139:chemically induced / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage*; D006397:Hematinics / Q000008:administration & dosage; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007165:Immunosuppression Therapy; D009369:Neoplasms / Q000097:blood* / Q000188:drug therapy; D010919:Placebos; D011788:Quality of Life; D011994:Recombinant Proteins
chemical_list: D000970:Antineoplastic Agents; D006397:Hematinics; D006454:Hemoglobins; D010919:Placebos; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa